L-asparaginase (L-asparagine aminohydrolase, E.C. 3.5.1.1) is the drug of choice used in combination therapy with other drugs in the treatment of acute lymphoblastic leukemia chemotherapy in children1. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.